IV-Only
Requires intravenous administration in clinical settings with cold-chain storage
Our oral combination therapy is designed to work where existing antivenoms cannot, in the field, in the first hours after a bite
Antivenom has barely changed since the 1890s. Its format limits where, when and for whom it works
Requires intravenous administration in clinical settings with cold-chain storage
Limited efficacy across different snake species
Treatment delays significantly reduce effectiveness
Cannot prevent or reverse local tissue damage causing lifelong disability
Manufacturing and administration expenses limit availability in affected regions
Antivenom has barely changed since the 1890s. Its format limits where, when and for whom it works
Requires intravenous administration in clinical settings with cold-chain storage
Limited efficacy across different snake species
Treatment delays significantly reduce effectiveness
Cannot prevent or reverse local tissue damage causing lifelong disability
Manufacturing and administration expenses limit availability in affected regions
A heat-stable oral therapy can be stocked in clinics, pharmacies and field kits, and taken immediately after a bite. Broad-spectrum design means it is not limited to a single venom family.

Red blood cells flow smoothly through an intact vessel. The wall holds everything in place. The surrounding tissue is protected.
Red blood cells flow smoothly through an intact vessel. The wall holds everything in place. The surrounding tissue is protected.
Muscle fibres are packed together. Each cell is wrapped in a protective membrane, and the tissue structure is intact. This structure is what the venom will reach first, and this is what we need to protect.
Muscle fibres are packed together. Each cell is wrapped in a protective membrane, and the tissue structure is intact. This structure is what the venom will reach first, and this is what we need to protect.
Where antivenom struggles, the local damage at the bite site, is exactly where Serpentium is designed to make the biggest difference. Surviving the bite shouldn't mean losing the limb.
Venoms tested across medically significant species
Preclinical, broad spectrumPeople suffer permanent disabilities from snakebite each year
Annual global burdenOf bite victims develop tissue damage that antivenom cannot address
Unmet clinical needOur oral therapy is designed to cover the venom families responsible for the majority of global envenomings, starting with the four species that cause the highest burden in India








































We use cookies to improve your experience and analyse site traffic. By continuing, you agree to our Cookie Policy.